Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Masimo ( (MASI) ) has shared an update.
On December 3, 2025, Masimo Corporation held its 2025 Investor Day, where CEO Katie Szyman and other executives presented the company’s long-term strategy and financial targets. The company reaffirmed its 2025 financial guidance and announced ambitious growth targets through 2028, including a revenue CAGR of 7%-10%, operating margin of 30%, and cumulative operating cash flow of approximately $1 billion from 2026-2028. Masimo emphasized its focus on patient outcomes, technology innovation, and commercial execution as key pillars for future growth.
The most recent analyst rating on (MASI) stock is a Buy with a $210.00 price target. To see the full list of analyst forecasts on Masimo stock, see the MASI Stock Forecast page.
Spark’s Take on MASI Stock
According to Spark, TipRanks’ AI Analyst, MASI is a Neutral.
Masimo’s overall stock score reflects significant financial challenges, with declining revenue and profitability being the most impactful factors. The earnings call provided some positive insights with strong revenue growth and strategic partnerships, but these are offset by valuation concerns due to negative earnings and lack of dividends. Technical analysis shows mixed signals, with short-term bullish momentum but longer-term bearish trends.
To see Spark’s full report on MASI stock, click here.
More about Masimo
Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Masimo’s innovations empower clinicians to transform patient care, with its SET® Measure-through Motion and Low Perfusion™ pulse oximetry being a notable product used on over 200 million patients annually worldwide.
Average Trading Volume: 712,585
Technical Sentiment Signal: Sell
Current Market Cap: $7.64B
For detailed information about MASI stock, go to TipRanks’ Stock Analysis page.